PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAcrivon Therapeutics
Acrivon Therapeutics(ACRV)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bevifimod
carcinoma
,
urologic neoplasms
,
ovarian neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
endometrioid carcinoma
,
transitional cell carcinoma
,
adenocarcinoma
,
ovarian epithelial carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
PREXASERTIB
carcinoma
,
urologic neoplasms
,
ovarian neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
endometrioid carcinoma
,
transitional cell carcinoma
,
adenocarcinoma
,
ovarian epithelial carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
Arm1
urologic neoplasms
,
carcinoma
,
ovarian neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
endometrioid carcinoma
,
transitional cell carcinoma
,
adenocarcinoma
,
ovarian epithelial carcinoma
Arm2
urologic neoplasms
,
carcinoma
,
ovarian neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
endometrioid carcinoma
,
transitional cell carcinoma
,
adenocarcinoma
,
ovarian epithelial carcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use